Origins and prevalence of the American Founder Mutation of MSH2

被引:31
作者
Clendenning, Mark [1 ]
Baze, Mark E. [2 ]
Sun, Shuying [3 ]
Walsh, Kyle [2 ]
Liyanarachchi, Sandya [1 ]
Fix, Dan [1 ]
Schunemann, Victoria [2 ]
Comeras, Ilene [2 ]
Deacon, Molly [4 ]
Lynch, Jane F. [4 ]
Gong, Gordon [4 ]
Thomas, Brittany C. [5 ]
Thibodeau, Stephen N. [5 ]
Lynch, Henry T. [4 ]
Hampel, Heather [2 ]
De la Chapelle, Albert [1 ]
机构
[1] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA
[4] Creighton Univ, Sch Med, Dept Prevent Med, Omaha, NE 68178 USA
[5] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA
关键词
D O I
10.1158/0008-5472.CAN-07-6599
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Large germline deletions within the mismatch repair gene MSH2 account for a significant proportion (up to 20%) of all deleterious mutations of this gene which are associated with Lynch syndrome. An exons 1 to 6 deletion of MSH2, originally reported in nine families, has been associated with a founding event within the United States, which genealogic studies had previously dated to 1727, and the number of present day carriers was estimated to be 18,981. Here, we report the development of a robust multiplex PCR which has assisted in the detection of 32 new families who carry the MSH2 American Founder Mutation (AFM). By offering testing to family members, 126 carriers of the AFM have been identified. Extensive genealogic studies have connected 27 of the 41 AFM families into seven extended pedigrees. These extended families have been traced back to around the 18th century without any evidence of further convergence between them. Characterization of the genomic sequence flanking the deletion and the identification of a common disease haplotype of between 0.6 and 2.3 Mb in all probands provides evidence for a common ancestor between these extended families. The DMLE+2.2 software predicts an age of similar to 500 years (95% confidence interval, 425-625) for this mutation. Taken together, these data are suggestive of an earlier founding event than was first thought, which likely occurred in a European or a Native American population. The consequences of this finding would be that the AFM is significantly more frequent in the United States than was previously predicted.
引用
收藏
页码:2145 / 2153
页数:9
相关论文
共 23 条
[1]   MEASURING THE STRENGTH OF ASSOCIATIONS BETWEEN HLA ANTIGENS AND DISEASES [J].
BENGTSSON, BO ;
THOMSON, G .
TISSUE ANTIGENS, 1981, 18 (05) :356-363
[2]   The 5′ Region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences [J].
Charbonnier, FC ;
Baert-Desurmont, S ;
Liang, P ;
Di Fiore, F ;
Martin, C ;
Frerot, S ;
Olschwang, S ;
Wang, Q ;
Buisine, MP ;
Gilbert, B ;
Nilbert, M ;
Lindblom, A ;
Frebourg, T .
HUMAN MUTATION, 2005, 26 (03) :255-261
[3]   Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer). [J].
Hampel, H ;
Frankel, WL ;
Martin, E ;
Arnold, M ;
Khanduja, K ;
Kuebler, P ;
Nakagawa, H ;
Sotamaa, K ;
Prior, TW ;
Westman, J ;
Panescu, J ;
Fix, D ;
Lockman, J ;
Comeras, I ;
de la Chapelle, A ;
Ellison, C ;
Melvin, S ;
Winston, J ;
Adeli, A ;
Burak, W ;
Chadwick, R ;
Elkhatib, I ;
Hemingway, T ;
Jamieson, K ;
Johnson, C ;
LaJeunesse, J ;
Liyanarachchi, S ;
Rangel, P ;
Soble, D ;
Walker, M ;
Wise, T ;
Zhang, Y ;
Schlanger, R ;
Aguilar, P ;
Hura, D ;
Keith, J ;
Kerner, B ;
Lavalle, G ;
Taylor, C ;
Vara, T ;
Zangmeister, J ;
DeVictor, S ;
Hines, L ;
Lindsey, M ;
Madhavan, J ;
Padmanabhan, A ;
Hamelberg, K ;
Niemann, T ;
Behrens, BC ;
Blair, SC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (18) :1851-1860
[4]   Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients [J].
Hampel, Heather ;
Frankel, Wendy ;
Panescu, Jenny ;
Lockman, Janet ;
Sotamaa, Kaisa ;
Fix, Daniel ;
Comeras, Ilene ;
La Jeunesse, Jennifer ;
Nakagawa, Hidewaki ;
Westman, Judith A. ;
Prior, Thomas W. ;
Clendenning, Mark ;
Penzone, Pamela ;
Lombardi, Janet ;
Dunn, Patti ;
Cohn, David E. ;
Copeland, Larry ;
Eaton, Lynne ;
Fowler, Jeffrey ;
Lewandowski, George ;
Vaccarello, Luis ;
Bell, Jeffrey ;
Reid, Gary ;
de la Chapelle, Albert .
CANCER RESEARCH, 2006, 66 (15) :7810-7817
[5]   Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene [J].
Heath, KE ;
Day, INM ;
Humphries, SE .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (04) :272-280
[6]   A high-resolution recombination map of the human genome [J].
Kong, A ;
Gudbjartsson, DF ;
Sainz, J ;
Jonsdottir, GM ;
Gudjonsson, SA ;
Richardsson, B ;
Sigurdardottir, S ;
Barnard, J ;
Hallbeck, B ;
Masson, G ;
Shlien, A ;
Palsson, ST ;
Frigge, ML ;
Thorgeirsson, TE ;
Gulcher, JR ;
Stefansson, K .
NATURE GENETICS, 2002, 31 (03) :241-247
[7]  
Labuda M, 1996, AM J HUM GENET, V59, P633
[8]   Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome - A systematic review [J].
Lindor, Noralane M. ;
Petersen, Gloria M. ;
Hadley, Donald W. ;
Kinney, Anita Y. ;
Miesfeldt, Susan ;
Lu, Karen H. ;
Lynch, Patrick ;
Burke, Wylie ;
Press, Nancy .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (12) :1507-1517
[9]   American founder mutation for Lynch syndrome - Prevalence estimates and implications [J].
Lynch, HT ;
de la Chapelle, A ;
Hampel, H ;
Wagner, A ;
Fodde, R ;
Lynch, JF ;
Okimoto, R ;
Clark, MB ;
Coronel, S ;
Trowonou, A ;
Fu, YX ;
Haynatzki, GR ;
Gong, G .
CANCER, 2006, 106 (02) :448-452
[10]   A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States [J].
Lynch, HT ;
Coronel, SM ;
Okimoto, R ;
Hampel, H ;
Sweet, K ;
Lynch, JF ;
Barrows, A ;
Wijnen, J ;
van der Klift, H ;
Franken, P ;
Wagner, A ;
Fodde, R ;
de la Chapelle, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (06) :718-724